Stockscreener 앱 받기
33.49
1.18%
0.39
시간 외 거래:
33.49
전일 마감가:
$33.10
열려 있는:
$33.25
하루 거래량:
143.88K
Relative Volume:
0.36
시가총액:
$1.51B
수익:
$45.95M
순이익/손실:
$-48.88M
주가수익비율:
-30.09
EPS:
-1.1129
순현금흐름:
$109.67M
1주 성능:
+3.97%
1개월 성능:
-10.31%
6개월 성능:
+31.59%
1년 성능:
+141.28%
1일 변동 폭
$33.03
$34.40
1주일 범위
$31.85
$35.11
52주 변동 폭
$10.62
$38.04
Septerna Inc Stock (SEPN) Company Profile
명칭
Septerna Inc
전화
650-338-3533
주소
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
33.49 | 1.49B | 45.95M | -48.88M | 109.67M | -1.1129 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | Raymond James | Strong Buy |
| 2025-12-15 | 개시 | Truist | Buy |
| 2025-11-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | 개시 | H.C. Wainwright | Buy |
| 2025-02-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-19 | 개시 | JP Morgan | Overweight |
| 2024-11-19 | 개시 | TD Cowen | Buy |
| 2024-11-19 | 개시 | Wells Fargo | Overweight |
모두보기
Septerna Inc 주식(SEPN)의 최신 뉴스
Septerna Inc (SEPN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Septerna, Inc. Revenue Breakdown – NASDAQ:SEPN - TradingView
SEPN|Septerna Inc|Price:33.100| - TradingKey
Septerna Inc (SEPN) Balance Sheet - TradingKey
TradingKey - TradingKey
Septerna Inc (SEPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Septerna Inc (SEPN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SEPN Q1 2026 Earnings: Narrower-than-Expected Loss Surprises the MarketInvestor Earnings Call - dars.gov.et
SEPN|Septerna Inc|Price:33.100|Chg%:-0.370 - TradingKey
Septerna Inc (SEPN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
3 Small-Cap Stocks with ‘Strong Buy’ Ratings and 40%+ Upside, According to Analysts - TipRanks
Septerna President and COO Elizabeth Bhatt sells 4,000 shares for $135,974 - Bitget
Septerna president & COO Elizabeth Bhatt sells $135,974 in stock - Investing.com
Form 4 Septerna Inc For: 17 July By Investing.com - Investing.com Nigeria
Septerna (SEPN) president sells 4,000 shares and exercises 4,000 options under plan - Stock Titan
Septerna (SEPN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Septerna, Inc. (SEPN) Reports Q3 Loss, Misses Revenue Estimates - MSN
Septerna, Inc. SEC Filing (Jul 15, 2026) - Stock Titan
Septerna Inc. (SEPN) Declines 1.33%, Approaching Key Support at $32.38Relative Volume - dars.gov.et
Is Septerna (SEPN) Fully Valued Following Its Russell Index Inclusions? - simplywall.st
Septerna (SEPN) Is Up 7.1% After Broad Russell Growth Index Additions Has The Bull Case Changed? - Sahm
Septerna Inc stock hits all-time high at 38.01 USD - Investing.com UK
Septerna Inc stock hits all-time high at 38.01 USD By Investing.com - Investing.com Australia
Septerna (SEPN) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
SEPN Q1 2026 Earnings: Smaller-than-expected loss as clinical-stage biotech advancesEarnings Yield Spread - dars.gov.et
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? - Yahoo Finance
Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors? - The Motley Fool
Septerna Inc. (SEPN) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Steady Pipeline ProgressRevenue Surprise History - dars.gov.et
Septerna (SEPN) SVP Long exercises options and sells 3,333 shares in Rule 10b5-1 trades - Stock Titan
Is Septerna, Inc. (SEPN) Stock a Biotech Opportunity With a Potential First-in-Class Hypoparathyroidism Treatment? - Yahoo Finance
Septerna Inc. (SEPN) Slides 2.63% as Stock Tests Key Support Near $32Max Pain Level - dars.gov.et
Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR) - The Globe and Mail
Septerna Inc. (SEPN) Slips 1.79% as Stock Tests Key Support LevelsInitial Balance - dars.gov.et
Guggenheim cuts Septerna stock price target to $45 on CSU study risk By Investing.com - Investing.com India
SEPN Maintained by Guggenheim -- Price Target Lowered to $45.00 - GuruFocus
Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating - marketscreener.com
SEPN Maintains Buy RatingPrice Target Raised to $43.00 by Tru - GuruFocus
SEPN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $40 - GuruFocus
Septerna (SEPN) Is Down 7.1% After Broad Russell Index Additions Has The Bull Case Changed? - simplywall.st
Guggenheim cuts Septerna stock price target to $45 on CSU study risk - Investing.com South Africa
Analysts Are Bullish on Top Technology Stocks: Akamai (AKAM), Procore Technologies (PCOR) - The Globe and Mail
Septerna stock maintained at Buy by H.C. Wainwright after rival setback - Investing.com
H.C. Wainwright Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Truist raises Septerna stock price target to $43 on hypoparathyroidism outlook - Investing.com
5 Best Up and Coming Pharmaceutical Stocks to Buy Now - Insider Monkey
Septerna, Inc. Files 8-K Detailing Annual Meeting Results and Company Information – June 2026 - Minichart
Septerna chief people officer Samira Shaikhly sells $76,622 in stock - Investing.com UK
Form 4 Septerna Inc For: 30 June By Investing.com - Investing.com UK
Septerna (NASDAQ: SEPN) director-linked funds get 15,000-share option - Stock Titan
Septerna chief people officer Samira Shaikhly sells $76,622 in stock By Investing.com - Investing.com South Africa
Septerna Inc (SEPN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):